Mengjiao Cai

2.7k total citations · 1 hit paper
21 papers, 1.1k citations indexed

About

Mengjiao Cai is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Mengjiao Cai has authored 21 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in Mengjiao Cai's work include RNA modifications and cancer (4 papers), Ubiquitin and proteasome pathways (4 papers) and Glycosylation and Glycoproteins Research (3 papers). Mengjiao Cai is often cited by papers focused on RNA modifications and cancer (4 papers), Ubiquitin and proteasome pathways (4 papers) and Glycosylation and Glycoproteins Research (3 papers). Mengjiao Cai collaborates with scholars based in China, United States and Hong Kong. Mengjiao Cai's co-authors include Shuai Wang, Xiangfei Meng, Jingyi Yang, Mingming Xiao, Jia Guo, Yaodong Li, Xianjun Zeng, Bo-Kyeong Kang, Bo Xu and Jinlu Ma and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Nature Cell Biology.

In The Last Decade

Mengjiao Cai

19 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A deep learning algorithm using CT images to screen for Corona virus disease (COVID-19)

2021 699 citations Shuai Wang, Bo-Kyeong Kang et al. European Radiology profile →

Peers

Countries citing papers authored by Mengjiao Cai

Since Specialization

Citations

This map shows the geographic impact of Mengjiao Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengjiao Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengjiao Cai more than expected).

Fields of papers citing papers by Mengjiao Cai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengjiao Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengjiao Cai. The network helps show where Mengjiao Cai may publish in the future.

Co-authorship network of co-authors of Mengjiao Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Mengjiao Cai. A scholar is included among the top collaborators of Mengjiao Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengjiao Cai. Mengjiao Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	USP25 maintains KRAS expression and inhibiting the deubiquitinase suppresses KRAS signaling in human cancer 2025 ·Journal of Biological Chemistry ·(unknown), (unknown), (unknown), Lingzhi Wu, Mengjiao Cai, (unknown), Xiang Shen, Suxia Han, Guang‐Xue Liu, Jin Peng, Pumin Zhang	0
2	A ROS-mediated oxidation-O-GlcNAcylation cascade governs ferroptosis 2025 ·Nature Cell Biology ·(unknown), (unknown), Chunyan Hou, (unknown), Shiya Zhu, Yihan Peng, Changmin Peng, Ping Li, Heng Meng, Yuguo Xia, (unknown), (unknown), (unknown), Gary M. Kupfer, Mengjiao Cai, (unknown), Junfeng Ma, (unknown), Suxia Han, (unknown)	8
3	Transforming growth factor-β (TGF-β) signaling pathway-related genes in predicting the prognosis of colon cancer and guiding immunotherapy 2023 ·SHILAP Revista de lepidopterología ·Jie Chen, (unknown), (unknown), Jin Wang, (unknown), (unknown), (unknown), (unknown), Mengjiao Cai, Jinlu Ma	1
4	Targeting Tumor Physical Microenvironment for Improved Radiotherapy 2022 ·Small Methods ·Jin Wang, Yulong Han, Yuan Li, (unknown), Mengjiao Cai, Xinyue Zhang, Jie Chen, Chao Ji, Jinlu Ma, Feng Xu	28
5	Dynamic Nomogram Based on the Metastatic Number and Sites and Therapy Strategies Predicting the Prognosis of Patients with Metastatic Cervical Cancer 2022 ·International Journal of Women s Health ·Yuan Ma, Jing Li, (unknown), Mengjiao Cai, Xiaozhi Zhang, Jinlu Ma	1
6	A Review of Intelligent Connected Vehicle Cooperative Driving Development 2022 ·Mathematics ·(unknown), Yi Han, (unknown), (unknown), Mengjiao Cai, Ming Liu, Lujia Wang	36
7	Targeting Tumor Physical Microenvironment for Improved Radiotherapy (Small Methods 11/2022) 2022 ·Small Methods ·Jin Wang, Yulong Han, Yuan Li, (unknown), Mengjiao Cai, Xinyue Zhang, Jie Chen, Chao Ji, Jinlu Ma, Feng Xu	0
8	Ubiquitin‐specific protease 28 deubiquitinates TCF7L2 to govern the action of the Wnt signaling pathway in hepatic carcinoma 2022 ·Cancer Science ·(unknown), Mengjiao Cai, Lingzhi Wu, (unknown), Yuetong Chen, (unknown), Suxia Han, Pumin Zhang	13
9	The SPOP-ITCH Signaling Axis Protects Against Prostate Cancer Metastasis 2021 ·Frontiers in Oncology ·Jinlu Ma, Mengjiao Cai, Yaqi Mo, (unknown), (unknown), Yuan Ma, Jie Chen, Suxia Han, Bo Xu	7
10	A deep learning algorithm using CT images to screen for Corona virus disease (COVID-19) breakdown → 2021 ·European Radiology ·Shuai Wang, Bo-Kyeong Kang, Jinlu Ma, Xianjun Zeng, Mingming Xiao, Jia Guo, Mengjiao Cai, Jingyi Yang, Yaodong Li, Xiangfei Meng, Bo Xu	699
11	SPOP promotes CDCA5 degradation to regulate prostate cancer progression via the AKT pathway 2021 ·Neoplasia ·(unknown), Jing Wang, Yue Zhu, (unknown), Chenchen He, Mengjiao Cai, Jinlu Ma, Yi Wang, Suxia Han	16
12	Identification of significant genes and therapeutic agents for breast cancer by integrated genomics 2021 ·Bioengineered ·(unknown), (unknown), (unknown), (unknown), Jie Chen, Xin Liang, Mengjiao Cai	6
13	Tamoxifen induces fatty liver disease in breast cancer through the MAPK8/FoxO pathway 2020 ·SHILAP Revista de lepidopterología ·Liuyun Gong, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Mengjiao Cai, Chenchen He, Jinlu Ma, Suxia Han	13
14	RECQL5 plays an essential role in maintaining genome stability and viability of triple‐negative breast cancer cells 2019 ·Cancer Medicine ·Jin Peng, Lichun Tang, Mengjiao Cai, Huan Chen, Jiemin Wong, Pumin Zhang	16
15	Nuclear Receptor Coactivator 2 Promotes Human Breast Cancer Cell Growth by Positively Regulating the MAPK/ERK Pathway 2019 ·Frontiers in Oncology ·Mengjiao Cai, Xin Liang, (unknown), Huan Chen, Yiping Dong, Lingzhi Wu, (unknown), Suxia Han	21
16	Disruption of peroxisome function leads to metabolic stress, mTOR inhibition, and lethality in liver cancer cells 2018 ·Cancer Letters ·Mengjiao Cai, (unknown), Wenchao Wang, (unknown), Ping Wu, Suxia Han, Huan Chen, Pumin Zhang	47
17	Autoantibodies against glucose-regulated protein 78 as serological biomarkers in metastatic and recurrent hepatocellular carcinoma 2017 ·Oncotarget ·Xia Ying, Suxia Han, Chenchen He, Congya Zhou, Yiping Dong, Mengjiao Cai, Xin Sui, (unknown), (unknown), Yuanyuan Zhang, Wenli Gou, Clifford Mason, Qing Zhu	10
18	MiR-21 promotes intrahepatic cholangiocarcinoma proliferation and growth in vitro and in vivo by targeting PTPN14 and PTEN 2015 ·Oncotarget ·Lijuan Wang, Chenchen He, Xin Sui, Mengjiao Cai, Congya Zhou, Jinlu Ma, Lei Wu, Hao Wang, Suxia Han, Qing Zhu	95
19	[Expression and clinical significance of PTPN14 in cholangiocarcinoma]. 2015 ·PubMed ·Lijuan Wang, Wenjin Xi, Guoxu Zheng, Congya Zhou, Guihua Jin, Chenchen He, Mengjiao Cai, Qing Zhu	3
20	Serum dickkopf-1 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancer 2015 ·Oncotarget ·Suxia Han, (unknown), Xin Sui, Chenchen He, Mengjiao Cai, Jinlu Ma, Yuanyuan Zhang, Congya Zhou, (unknown), Armando Varela‐Ramírez, Qing Zhu	66

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact